To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Hawaii’s housing market has long faced challenges, with a ...

LONDON – It's so far, so good for adaptive pathways, with the EMA's final report on its pilot scheme concluding that staggered approval from a small patient subgroup to an increasingly wide patient ...

An EMA pilot study looking at progressive licensing of new drugs has found that there are merits to the approach, but further work is needed before the concept can be rolled out across the EU. The EMA ...

LONDON – Pluristem Therapeutics Inc.'s PLX placenta-based cell therapy has been selected for the EMA adaptive pathways pilot, a designation the company said will save a lot of money and cut three to ...

As the impacts of climate change intensify, the need to better understand how societies and ecosystems can adapt—and where limits to adaptation may arise—has become more pressing than ever. Despite ...